- Home
- EUDA vs LUCD Comparison
EUDA vs LUCD Comparison
Compare EUDA & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EUDA
- LUCD
- Stock Information
- Founded
- EUDA 2021
- LUCD 2018
- Country
- EUDA Singapore
- LUCD United States
- Employees
- EUDA N/A
- LUCD N/A
- Industry
- EUDA Blank Checks
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EUDA Finance
- LUCD Health Care
- Exchange
- EUDA Nasdaq
- LUCD Nasdaq
- Market Cap
- EUDA 139.3M
- LUCD 119.7M
- IPO Year
- EUDA N/A
- LUCD 2021
- Fundamental
- Price
- EUDA $3.65
- LUCD $1.42
- Analyst Decision
- EUDA
- LUCD Strong Buy
- Analyst Count
- EUDA 0
- LUCD 4
- Target Price
- EUDA N/A
- LUCD $3.75
- AVG Volume (30 Days)
- EUDA 100.2K
- LUCD 853.2K
- Earning Date
- EUDA 01-01-0001
- LUCD 03-24-2025
- Dividend Yield
- EUDA N/A
- LUCD N/A
- EPS Growth
- EUDA N/A
- LUCD N/A
- EPS
- EUDA N/A
- LUCD N/A
- Revenue
- EUDA $3,811,496.00
- LUCD $4,346,000.00
- Revenue This Year
- EUDA $66.63
- LUCD $156.40
- Revenue Next Year
- EUDA $119.95
- LUCD $206.37
- P/E Ratio
- EUDA N/A
- LUCD N/A
- Revenue Growth
- EUDA N/A
- LUCD 79.00
- 52 Week Low
- EUDA $1.64
- LUCD $0.63
- 52 Week High
- EUDA $6.30
- LUCD $1.63
- Technical
- Relative Strength Index (RSI)
- EUDA 42.35
- LUCD 50.00
- Support Level
- EUDA $3.59
- LUCD $1.43
- Resistance Level
- EUDA $4.04
- LUCD $1.60
- Average True Range (ATR)
- EUDA 0.22
- LUCD 0.12
- MACD
- EUDA -0.02
- LUCD -0.01
- Stochastic Oscillator
- EUDA 9.38
- LUCD 50.00
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.